Objective: To evaluate the impact of a 36 months systematic, multidisciplinary follow-up management program on long-term medication adherence and the risk of cardiovascular readmission in patients with coronary artery disease after hospital discharge. Methods: This prospective randomized controlled trial consecutively enrolled 280 coronary artery disease patients discharged between January 2020 and August 2022. Patients were randomly allocated to either an intervention group(n=140) or a control group(n=140). The control group received routine discharge instructions, while the intervention group received an additional 36 months systematic telephone follow-up program, which included medication guidance, symptom monitoring, lifestyle intervention, and psychological support. The primary outcomes were the Morisky Medication Adherence scale(MMAS-8) score and the cardiovascular-related readmission rate. Continuous variables were compared using the t-test, and categorical variables were analyzed using the χ2 test or Fisher's exact test. Kaplan-Meier survival curves were constructed to estimate event-free survival, and differences between groups were assessed using the log-rank test. Cumulative incidence curves were plotted to illustrate the overall burden of events; Cox proportional hazards models were used to evaluate the association between follow-up management and rehospitalization risk. Results: Baseline characteristics were comparable between the two groups(all P>0.05). After 36 months of follow-up, the high adherence rate was 83.3%(110/132) in the intervention group compared to 49.2%(63/128) in the control group. The intervention group demonstrated significantly higher medication adherence, with higher Morisky scores and a greater proportion of patients with high adherence at all follow-up time points(all P<0.001). Furthermore, the intervention group experienced significantly lower rates of cardiovascular-related readmission(19.7% vs. 39.1%, P<0.001), all-cause readmission(26.5% vs. 48.4%, P<0.001), and major adverse cardiovascular events(23.5% vs. 42.2%, P=0.001). Kaplan-Meier analysis revealed a significantly higher event-free survival rate from cardiovascular readmission in the intervention group(Log-rank P<0.001). Multivariable Cox regression analysis showed that the follow-up management program was independently associated with a lower risk of readmission(HR=0.48, 95% CI 0.31-0.74, P=0.001). Conclusion: A 36 months systematic, multidisciplinary follow-up management program can significantly and sustainably improve medication adherence and reduce the risk of cardiovascular readmission by 52% in patients with CAD after discharge. This program represents an effective secondary prevention strategy for improving long-term prognosis. |
[1] VOS T,LIM S S,ABBAFATI C,et al.Global burden of 369 diseases and injuries in 204 countries and territories,1990—2019:a systematic analysis for the Global Burden of Disease Study 2019[J].Lancet,2020,396(10258):1204-1222.
[2] ZHANG Y,WU S H,FENDRICK A M,et al.Variation in medication adherence in heart failure[J].JAMA Intern Med,2013,173(6):468-470.
[3] HO P M,RUMSFELD J S,MASOUDI F A,et al.Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus[J].Arch Intern Med,2006,166(17):1836-1841.
[4] KRUMHOLZ H M,MERRILL A R,SCHONE E M,et al.Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission[J].Circ Cardiovasc Qual Outcomes,2009,2(5):407-413.
[5] 孙碧松.冠心病患者用药依从性低的原因分析及护理[J].医学信息(中旬刊),2011,24(9):4922-4923.
[6] LIU S,LI J,WAN D Y,et al.Effectiveness of eHealth self-management interventions in patients with heart failure:systematic review and meta-analysis[J].J Med Internet Res,2022,24(9):e38697.
[7] FELTNER C,JONES C D,CENÉ C W,et al.Transitional care interventions to prevent readmissions for persons with heart failure:a systematic review and meta-analysis[J].Ann Intern Med,2014,160(11):774-784.
[8] GONÇALVES-BRADLEY D C,LANNIN N A,CLEMSON L,et al.Discharge planning from hospital[J].Cochrane Database Syst Rev,2022,2(2):CD000313.
[9] THYGESEN K,ALPERT J S,JAFFE A S,et al.Fourth universal definition of myocardial infarction(2018)[J].Glob Heart,2018,13(4):305-338.
[10] 俞吉,冉烁,徐玲.Morisky用药依从性量表8条目在老年慢性病患者用药评价中的应用[J].临床药物治疗杂志,2020,18(11):63-66.
[11] WANG Y,KONG M C,KO Y.Psychometric properties of the 8-item Morisky Medication Adherence Scale in patients taking warfarin[J].Thromb Haemost,2012,108(4):789-795.
[12] MORISKY D E,ANG A,KROUSEL-WOOD M,et al.Predictive validity of a medication adherence measure in an outpatient setting[J].J Clin Hypertens,2008,10(5):348-354.
[13] 崔建国,徐文文,梁淑芹,等.信息化随访系统在出院冠心病患者治疗依从性中的作用[J].临床心血管病杂志,2019,35(2):127-130.
[14] 李凤荣,赵翠梅.基于PDCA管理模式的随访管理对老年冠心病介入治疗患者健康行为及服药依从性的影响[J].世界最新医学信息文摘(连续型电子期刊),2020,20(19):182,185.
[15] MCDONAGH T,METRA M.2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J].Russ J Cardiol,2023,28(1):5168.
[16] CHOW C K,JOLLY S,RAO-MELACINI P,et al.Association of diet,exercise,and smoking modification with risk of early cardiovascular events after acute coronary syndromes[J].Circulation,2010,121(6):750-758. |